PNGAY Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Premiums & Annuity Revenue	559,672	559,304	550,830	536,210	525,903	739,933
Total Interest & Dividend Income	85,740	57,496	44,184	87,382	107,162	200,459
Gain (Loss) on Sale of Investments	20,272	48,422	63,171	-60,312	-57,069	-11,605
Non-Insurance Activities Revenue	218,681	221,939	243,747	273,358	274,766	264,963
Other Revenue	68,541	68,541	61,712	70,238	33,881	79,266
Total Revenue	952,906	955,702	963,644	906,876	884,643	1,273,016
Revenue Growth (YoY)	16.79%	-0.82%	6.26%	2.51%	-30.51%	-3.55%
Policy Benefits	457,670	458,334	452,703	443,909	426,535	618,662
Policy Acquisition & Underwriting Costs	-	-	-	-	-	80,711
Selling, General & Administrative	82,479	82,452	80,473	80,212	76,401	174,783
Provision for Bad Debts	3,787	1,003	462	152	-23	242
Non-Insurance Activities Expense	86,019	89,745	111,889	117,378	107,616	102,011
Other Operating Expenses	43,410	43,718	47,586	41,328	32,948	41,450
Total Operating Expenses	738,727	740,614	764,396	754,920	722,315	1,104,333
Operating Income	214,179	215,088	199,248	151,956	162,328	168,683
Interest Expense	-28,491	-29,087	-26,376	-31,496	-22,698	-28,082
Currency Exchange Gain (Loss)	573	618	380	120	3,144	1,267
Other Non Operating Income (Expenses)	-1,069	-1,029	-2,757	-463	-439	-2,288
EBT Excluding Unusual Items	185,192	185,590	170,495	120,117	142,335	139,580
Gain (Loss) on Sale of Assets	-38	-	-	-	-	-
Asset Writedown	-17	-	-	-	-	-
Pretax Income	185,137	185,590	170,495	120,117	142,335	139,580
Income Tax Expense	28,732	27,289	23,762	10,843	7,518	17,778
Earnings From Continuing Ops.	156,405	158,301	146,733	109,274	134,817	121,802
Minority Interest in Earnings	-23,621	-23,523	-20,126	-23,609	-23,809	-20,184
Net Income	132,784	134,778	126,607	85,665	111,008	101,618
Net Income to Common	132,784	134,778	126,607	85,665	111,008	101,618
Net Income Growth	13.57%	6.45%	47.79%	-22.83%	9.24%	-28.99%
Shares Outstanding (Basic)	17,545	17,556	17,693	17,717	17,454	17,607
Shares Outstanding (Diluted)	18,421	18,107	18,107	18,074	17,710	17,771
Shares Change (YoY)	0.79%	-	0.18%	2.05%	-0.34%	-0.14%
EPS (Basic)	7.57	7.68	7.16	4.84	6.36	5.77
EPS (Diluted)	7.20	7.44	6.99	4.74	6.27	5.72
EPS Growth	12.67%	6.44%	47.47%	-24.40%	9.62%	-28.86%
Free Cash Flow	538,131	650,277	375,796	352,593	467,905	77,930
Free Cash Flow Per Share	29.21	35.91	20.75	19.51	26.42	4.38
Dividend Per Share	2.700	2.700	2.550	2.430	2.420	2.380
Dividend Growth	5.88%	5.88%	4.94%	0.41%	1.68%	8.18%
Operating Margin	22.48%	22.51%	20.68%	16.76%	18.35%	13.25%
Profit Margin	13.94%	14.10%	13.14%	9.45%	12.55%	7.98%
Free Cash Flow Margin	56.47%	68.04%	39.00%	38.88%	52.89%	6.12%
EBITDA	225,322	226,279	210,630	165,496	174,534	178,062
EBITDA Margin	23.65%	23.68%	21.86%	18.25%	19.73%	13.99%
D&A For EBITDA	11,143	11,191	11,382	13,540	12,206	9,379
EBIT	214,179	215,088	199,248	151,956	162,328	168,683
EBIT Margin	22.48%	22.51%	20.68%	16.76%	18.35%	13.25%
Effective Tax Rate	15.52%	14.70%	13.94%	9.03%	5.28%	12.74%
Revenue as Reported	1,140,324	1,140,324	1,141,346	1,031,863	985,186	1,287,675

Source: S&P Global Market Intelligence. Insurance template. Financial Sources.